Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

WithdrawnOBSERVATIONAL

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Human Papillomavirus Infection

Interventions

OTHER

Cervarix data collection

Safety monitoring: recording of all AEs during the study period using diary cards, follow-up visit or telephone contact.

OTHER

Data Collection

All adverse events will be recorded by diary card, follow-up visit or telephone contact.